Gemma Church talks to data visualisation company Golden Software about three decades in business, Microsoft bugs and working in the geoscience arena
In her series of profiles of bioinformatics companies, Sophia Ktori looks at the work of biosimulation specialist, Certara
In the high-octane world of motorbike racing, a balance between simulation and physical testing can be crucial to improved performance, writes Robert Roe
Gemma Church finds out how simulation software aids and optimises the decisions behind siting a wind farm
After a shaky start, interest in migrating HPC to the cloud is growing rapidly. Tom Wilkie reports
Andrew Jones looks ahead at what 2016 has in store for HPC and finds people, not technology, to be the most important issue
In her second article on cloud computing, Sophia Ktori looks at how both vendors and customers of informatics systems are having to change their IT culture
The R&D sector is increasingly turning to collaborative, partnered and outsourced projects to boost innovation, reduce costs and help expedite development, writes Sophia Ktori
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
